Progesterone-induced blocking factor (PIBF) and trophoblast invasiveness

Journal of Reproductive Immunology

Volumn 90, Issue 1, 2011, Pages 50-57

  Miko, E ^a   Halasz, M ^a   Jericevic Mulac, B ^b   Wicherek, L ^c   Arck, P ^d   Arato G ^e   Skret Magierlo, J ^f   Rukavina, D ^b   Szekeres Bartho, J ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e ST JOHN'S HOSPITAL   (Hungary)

^f Clinical Department of Obstetrics and Gynecology and State Hospital   (Poland)

Author keywords

Invasion; Leptin; PIBF

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; PARAFFIN; PROGESTERONE; PROGESTERONE INDUCED BLOCKING FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL LYSATE; CHORIOCARCINOMA; CONTROLLED STUDY; GENE SILENCING; HYDATIDIFORM MOLE; IMMUNOHISTOLOGY; MOLE (INSECTIVORA); MOUSE; NONHUMAN; PLACENTA; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MICROARRAY; RECEPTOR UPREGULATION; TROPHOBLAST; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; CHORIOCARCINOMA; DECIDUA; EMBRYO IMPLANTATION; FEMALE; HUMANS; HYDATIDIFORM MOLE; LEPTIN; PLACENTA; PLACENTATION; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PROGESTERONE; RECEPTORS, LEPTIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SUPPRESSOR FACTORS, IMMUNOLOGIC; TROPHOBLASTS; UTERINE NEOPLASMS;

EID: 79960028736     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.03.005     Document Type: Article

References (36)

1. Anderle C., Hammer A., Polgár B., Hartmann M., Wintersteiger R., Blaschitz A., Dohr G., Desoye G., Szekeres-Barthó J., Sedlmayr P. Human trophoblast cells express the immunomodulator progesterone-induced blocking factor. J. Reprod. Immunol. 2008, 79:26-36.
2. Attoub S., Noe V., Pirola L., Bruyneel E., Chastre E., Mareel M., Wymann M.P., Gespach C. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J. 2000, 14:2329-2338.
3. Bischof P., Meisser A., Campana A. Paracrine and autocrine regulators of trophoblast invasion: a review. Placenta 2000, 21(Suppl. A):S55-S60.
4. Bodner J., Ebenbichler C.F., Wolf H.J., Müller-Holzner E., Stanzl U., Gander R., Huter O., Patsch J.R. Leptin receptor in human term placenta: in situ hybridization and immunohistochemical localization. Placenta 1999, 20:677-682.
5. Check J.H., Check M.L. Evidence that failure to conceive despite apparent correction of ovulatory defects by follicle-maturing drugs may be related to premature trophoblast invasion. Med. Hypotheses 2002, 59:385-388.
6. Check J.H., Dix E., Wilson C., Check D. Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studies. Anticancer Res. 2010, 30:4921-4923.
7. Choi J.H., Park S.H., Leung P.C., Choi K.C. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J. Clin. Endocrinol. Metab. 2005, 90:207-210.
8. Behrendtsen O., Alexander C.M., Werb Z. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 1992, 114:447-456.
9. Cameo P., Bischof P., Calvo J.C. Effect of leptin on progesterone, human chorionic gonadotropin, and interleukin-6 secretion by human term trophoblast cells in culture. Biol. Reprod. 2003, 68:472-477.
10. Castellucci M., De Matteis R., Meisser A., Cancello R., Monsurrò V., Islami D., Sarzani R., Marzioni D., Cinti S., Bischof P. Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol. Hum. Reprod. 2000, 6:951-958.
11. Dai B., Cao Y., Liu W., Yang Y., Chen D., Duan E. Dual roles of progesterone in embryo implantation in mouse. Endocrine 2003, 21:123-132.
12. Das S.K., Yano S., Wang J., Edwards D.R., Nagase H., Dey S.K. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. Dev. Genet. 1997, 21:44-54.
13. Goldman S., Shalev E. Difference in progesterone receptor isoforms ratio, between early and late first trimester human trophoblast, is associated with differential cell invasion and matrix metalloproteinase2 (MMP2) expression. Biol. Reprod. 2006, 74:13-22. http://www.rbej.com/sfx_links?ui=1477-7827-3-56&bibl=B73.
14. Graham C.H., Hawley T.S., Hawley R.G., MacDougal J.R., Kerbel R.S., Khoo N., Lala P.K. Establishment and characterization of human trophoblast cells with extended life span. Exp. Cell Res. 1993, 206:204-211.
15. Henson M.C., Swan K.F., O'Neil J.S. Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet. Gynecol. 1998, 92:1020-1028.
16. Islami D., Bischof P. Leptin in the placenta. Leptin and Reproduction 2003, 201-220. Kluwer Academic/Plenum Publishers, New York. M.C. Henson, V.D. Castracane (Eds.).
17. Islami D., Bischof P., Chardonnens D. Possible interactions between leptin, gonadotrophin-releasing hormone (GnRH-I and II) and human chorionic gonadotrophin (hCG). Eur. J. Obstet. Gynecol. Reprod. Biol. 2003, 110:169-175.
18. Lachmann M., Gelbmann D., Kálmán E., Polgár B., Buschle M., Von Gabain A., Szekeres-Barthó J., Nagy E. PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome. Int. J. Cancer 2004, 112:51-60.
19. Li R.H., Yu M.M., Cheung A.N., Wong Y.F. Expression of leptin and leptin receptors in gestational trophoblastic diseases. Gynecol. Oncol. 2004, 95:299-306.
20. Librach C.L., Werb Z., Fitzgerald M.L., Chiu K., Corwin N.M., Esteves R.A., Grobelny D., Galardy R., Damsky C.H., Fisher S.J. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol. 1991, 113:437-449.
21. Luoh S.M., Di Marco F., Levin N., Armanini M., Xie M.H., Nelson C., Bennett G.L., Williams M., Spencer S.A., Gurney A., de Sauvage F.J. Cloning and characterization of a human leptin receptor using a biologically active leptin immunoadhesin. J. Mol. Endocrinol. 1997, 18:77-85.
22. Masuzaki H., Ogawa Y., Sagawa N., Hosoda K., Matsumoto T., Mise H., Nishimura H., Yoshimasa Y., Tanaka I., Mori T., Nakao K. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat. Med. 1997, 3:1029-1033.
23. Maymó J.L., Pérez Pérez A., Sánchez-Margalet V., Dueñas J.L., Calvo J.C., Varone C.L. Up-regulation of placental leptin by human chorionic gonadotropin. Endocrinology 2009, 150:304-313.
24. Maymó J.L., Pérez Pérez A., Gambino Y., Calvo J.C., Sánchez-Margalet V., Varone C.L. Review: Leptin gene expression in the placenta: regulation of a key hormone in trophoblast proliferation and survival. Placenta 2011, 32(Suppl. 2):S146-S153.
25. Polgár B., Nagy E., Mikó E., Varga P., Szekeres-Barthó J. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biol. Reprod. 2004, 71:1699-1705.
26. Poston L. Leptin and preeclampsia. Semin. Reprod. Med. 2002, 20:131-138.
27. Sagawa N., Yura S., Itoh H., Kakui K., Takemura M., Nuamah M.A., Ogawa Y., Masuzaki H., Nakao K., Fujii S. Possible role of placental leptin in pregnancy: a review. Endocrine 2002, 19:65-71.
28. Shih I.M. Gestational trophoblastic neoplasia: pathogenesis and potential therapeutic targets. Lancet Oncol. 2007, 8:642-650.
29. Shih I.M., Kurman R.J. Pathogenesis of gestational trophoblastic lesions. Molecular Pathology of Gynecologic Cancer 2007, 157-166. Humana Press Inc., Totowa, NJ. A. Giordano, A. Bovicelli, R.J. Kurman (Eds.).
30. Shimonovitz S., Hurwitz A., Hochner-Celnikier D., Dushnik M., Anteby E., Yagel S. Expression of gelatinase B by trophoblast cells: downregulation by progesterone. Am. J. Obstet. Gynecol. 1998, 178:457-461.
31. Spencer T.E., Burghardt R.C., Johnson G.A., Bazer F.W. Conceptus signals for establishment and maintenance of pregnancy. Anim. Reprod. Sci. 2004, 83:537-550.
32. Srivastava M.D., Thomas A., Srivastava B.I., Check J.H. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk. Lymphoma 2007, 48:1610-1617.
33. Szekeres-Bartho J., Kilaŕ F., Falkay G., Csernus V., Török A., Pacsa A.S. The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am. J. Reprod. Immunol. Microbiol. 1985, 9:15-18.
34. Toth B., Fischl A., Scholz C., Kuhn C., Friese K., Karamouti M., Makrigiannakis A., Jeschke U. Insulin and leptin receptors as possible new candidates for endocrine control in normal and disturbed human pregnancy. Mol. Hum. Reprod. 2009, 15:231-239.
35. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
36. Zhou Y., Damsky C.H., Fisher S.J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J. Clin. Invest. 1997, 9:2152-2164.